Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen R Stagg

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Thorax|July 6, 2013
Migration and tuberculosis in the UK: targeting screening for latent infection to those at greatest risk of diseaseMichelle E Kruijshaar, Ibrahim Abubakar, Helen R Stagg, et al.
BMJ (Clinical Research Ed.)|November 10, 2011
Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluationMark Jit, Helen R Stagg, Robert W Aldridge, et al.
The European Respiratory Journal|September 17, 2013
A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosisHelen R Stagg, Ted Cohen, Mercedes C Becerra, et al.
BMJ Global Health|August 14, 2025
Equity in protection: bridging global data gaps for an EBV vaccine-a systematic review and meta-analysisMarisa D Muckian, Ting Shi, Vesa Qarkaxhija, et al.
BMJ Open Respiratory Research|February 15, 2024
Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-upElizabeth F Walker, Mary Flook, Alison J Rodger, et al.
BMJ Open Respiratory Research|August 1, 2025
Temporal complexity in missed doses of rifampicin-sensitive anti-tuberculosis treatment: a prospective cohort study in TanzaniaLilian Tuwabunze, Kassim Salim Msaji, Alphonce Liyoyo, et al.
BMC Infectious Diseases|February 4, 2023
Mendelian randomisation identifies priority groups for prophylactic EBV vaccinationMarisa D Muckian, James F Wilson, Graham S Taylor, et al.
Reviews in Medical Virology|April 25, 2026
Beyond the Usual Suspects: Emerging Associations Between Epstein-Barr Virus Infection/Infectious Mononucleosis and CancersMarisa D Muckian, Graham S Taylor, John Diaz-Decaro, et al.
Annals of Internal Medicine|August 12, 2014
Treatment of latent tuberculosis infection: a network meta-analysisHelen R Stagg, Dominik Zenner, Ross J Harris, et al.
BMC Medicine|March 24, 2016
Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic reviewHollie-Ann Hatherell, Caroline Colijn, Helen R Stagg, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Thorax|July 6, 2013
Migration and tuberculosis in the UK: targeting screening for latent infection to those at greatest risk of diseaseMichelle E Kruijshaar, Ibrahim Abubakar, Helen R Stagg, et al.
BMJ (Clinical Research Ed.)|November 10, 2011
Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluationMark Jit, Helen R Stagg, Robert W Aldridge, et al.
The European Respiratory Journal|September 17, 2013
A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosisHelen R Stagg, Ted Cohen, Mercedes C Becerra, et al.
BMJ Global Health|August 14, 2025
Equity in protection: bridging global data gaps for an EBV vaccine-a systematic review and meta-analysisMarisa D Muckian, Ting Shi, Vesa Qarkaxhija, et al.
BMJ Open Respiratory Research|February 15, 2024
Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-upElizabeth F Walker, Mary Flook, Alison J Rodger, et al.
BMJ Open Respiratory Research|August 1, 2025
Temporal complexity in missed doses of rifampicin-sensitive anti-tuberculosis treatment: a prospective cohort study in TanzaniaLilian Tuwabunze, Kassim Salim Msaji, Alphonce Liyoyo, et al.
BMC Infectious Diseases|February 4, 2023
Mendelian randomisation identifies priority groups for prophylactic EBV vaccinationMarisa D Muckian, James F Wilson, Graham S Taylor, et al.
Reviews in Medical Virology|April 25, 2026
Beyond the Usual Suspects: Emerging Associations Between Epstein-Barr Virus Infection/Infectious Mononucleosis and CancersMarisa D Muckian, Graham S Taylor, John Diaz-Decaro, et al.
Annals of Internal Medicine|August 12, 2014
Treatment of latent tuberculosis infection: a network meta-analysisHelen R Stagg, Dominik Zenner, Ross J Harris, et al.
BMC Medicine|March 24, 2016
Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic reviewHollie-Ann Hatherell, Caroline Colijn, Helen R Stagg, et al.
Pageof 8